Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangyi Jiang

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|September 9, 2021
Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling StudiesBoshi Huang, Tiziana Ginex, F Javier Luque, et al.
Journal of Medicinal Chemistry|January 21, 2022
Development of Novel Dihydrofuro[3,4-<i>d</i>]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181CDongwei Kang, Yanying Sun, Da Feng, et al.
European Journal of Medicinal Chemistry|August 21, 2024
Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimizationLanlan Jing, Gaochan Wu, Fabao Zhao, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid ModulatorsXujie Zhang, Lin Sun, Shujing Xu, et al.
Bioorganic & Medicinal Chemistry|September 25, 2021
Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitorsJing Li, Xiangyi Jiang, Alexej Dick, et al.
European Journal of Medicinal Chemistry|July 2, 2023
Discovery of novel diarypyrimidine derivatives bearing six-membered non-aromatic heterocycles as potent HIV-1 NNRTIs with improved anti-resistance and drug-like profilesXiangyi Jiang, Boshi Huang, Waleed A Zalloum, et al.
Chemical Biology & Drug Design|November 2, 2018
Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors by exploring the structure-activity relationship of solvent-exposed regions IDongwei Kang, Zhao Wang, Meng Chen, et al.
Bioorganic Chemistry|January 9, 2026
Discovery of novel diarylpyrimidine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors: Design, synthesis and biological activity evaluationHao Lin, Zhongxia Zhou, Lin Zheng, et al.
Journal of Medicinal Chemistry|July 13, 2026
Targeted Degradation of Capsid by Host-Hijacking PROTAC Overcomes Drug ResistanceMei Wang, Zeyu Peng, Yang Zhou, et al.
RSC Medicinal Chemistry|October 20, 2023
Identification of novel 1,2,3-triazole isatin derivatives as potent SARS-CoV-2 3CLpro inhibitors <i>via</i> click-chemistry-based rapid screeningXiangyi Jiang, Jing Li, Antonio Viayna, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|September 9, 2021
Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling StudiesBoshi Huang, Tiziana Ginex, F Javier Luque, et al.
Journal of Medicinal Chemistry|January 21, 2022
Development of Novel Dihydrofuro[3,4-<i>d</i>]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181CDongwei Kang, Yanying Sun, Da Feng, et al.
European Journal of Medicinal Chemistry|August 21, 2024
Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimizationLanlan Jing, Gaochan Wu, Fabao Zhao, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid ModulatorsXujie Zhang, Lin Sun, Shujing Xu, et al.
Bioorganic & Medicinal Chemistry|September 25, 2021
Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitorsJing Li, Xiangyi Jiang, Alexej Dick, et al.
European Journal of Medicinal Chemistry|July 2, 2023
Discovery of novel diarypyrimidine derivatives bearing six-membered non-aromatic heterocycles as potent HIV-1 NNRTIs with improved anti-resistance and drug-like profilesXiangyi Jiang, Boshi Huang, Waleed A Zalloum, et al.
Chemical Biology & Drug Design|November 2, 2018
Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors by exploring the structure-activity relationship of solvent-exposed regions IDongwei Kang, Zhao Wang, Meng Chen, et al.
Bioorganic Chemistry|January 9, 2026
Discovery of novel diarylpyrimidine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors: Design, synthesis and biological activity evaluationHao Lin, Zhongxia Zhou, Lin Zheng, et al.
Journal of Medicinal Chemistry|July 13, 2026
Targeted Degradation of Capsid by Host-Hijacking PROTAC Overcomes Drug ResistanceMei Wang, Zeyu Peng, Yang Zhou, et al.
RSC Medicinal Chemistry|October 20, 2023
Identification of novel 1,2,3-triazole isatin derivatives as potent SARS-CoV-2 3CLpro inhibitors <i>via</i> click-chemistry-based rapid screeningXiangyi Jiang, Jing Li, Antonio Viayna, et al.
Pageof 5